Misuse of Drugs Act 1975

2A Meaning of CBD product

(1)

CBD product means a product that—

(a)

contains cannabidiol; and

(b)

either—

(i)

does not contain a specified substance; or

(ii)

contains specified substances in an amount that is no more than 2% of the sum of the amount of cannabidiol and the amount of specified substances in the product; and

(c)

does not contain any other controlled drug; and

(d)

does not contain any other psychoactive substance (as defined in section 9 of the Psychoactive Substances Act 2013).

(2)

In this section, specified substance means a substance that—

(a)

naturally occurs in cannabis; and

(b)

is—

(i)

a tetrahydrocannabinol; or

(ii)

an isomer, ester, or ether of a tetrahydrocannabinol; or

(iii)

an ester or ether of an isomer of a tetrahydrocannabinol; or

(iv)

a salt of any substance described in subparagraphs (i) to (iii); or

(v)

a substance that has a structure substantially similar to that of any substance described in subparagraphs (i) to (iv); and

(c)

for substances listed in paragraph (b)(ii) to (v), is capable of inducing more than a minor psychoactive effect, by any means, in a person.

Section 2A: inserted, on 18 December 2018, by section 5 of the Misuse of Drugs (Medicinal Cannabis) Amendment Act 2018 (2018 No 54).